SGLT inhibitor Tofogliflozin hydrate, Purity ≥98%

Cat. No.: X24-07-ZQ531

SGLT inhibitor Tofogliflozin hydrate, Purity ≥98%

Synonym: 1201913-82-7; SGLT inhibitor; CSG-452 hydrate; CSG452; CSG 452

  • CAS Number: 1201913-82-7
  • Compound CID: 46908928
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Tofogliflozin hydrate, soluble in DMSO, water and ethanol, is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Weight
404.45
Molecular Formula
C22H28O7
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 82 mg/mL (202.74 mM); Water: 4 mg/mL (9.88 mM); Ethanol: 82 mg/mL (202.74 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tofogliflozin hydrate is an SGLT inhibitor used to assess its efficacy in lowering blood glucose levels for diabetes research.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0